Affy Rolls Out Axiom Genotyping Platform, Inks 100K-Sample GWAS Deal with Kaiser, UCSF

Axiom is Affy's first major new genotyping offering since the firm launched its 1.8-million-marker SNP Array 6.0 two years ago. Affy believes that Axiom's customizable format will give it an advantage in the highly competitive genome-wide association studies market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.